PERRIGO COMPANY PLC (NYSE: PRGO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PERRIGO COMPANY PLC

PERRIGO COMPANY PLC (NYSE: PRGO)
Listen to this Section


$10.47
+0.0050 ( +0.05% ) 1.1M

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Market Data


Open $10.47
Previous Close $10.46
Volume 1.1M
Market Cap $1.45B
Day Range $10.31 - $10.87
52 Week Range $9.23 - $28.44
Shares Outstanding 138.37M
Change % +0.05%
Net Change ▲ 0.0050
Insider Ownership N/A
Exchange NYSE
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year1991
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 33,041.00

Date Type Amount Purchased Purchaser
2025-11-14 Buy 7500.00 Parker Geoffrey M.
2025-09-10 Buy 1255.00 Lennox Abigail
2025-09-09 Buy 1000.00 Atkinson Charles
2025-09-09 Buy 1000.00 Atkinson Charles
2025-08-22 Buy 1488.00 Willis Robert
2025-08-22 Buy 1488.00 Willis Robert
2025-08-19 Buy 4375.00 Parker Geoffrey M.
2025-08-19 Buy 3000.00 Bezerra Eduardo Guarita
2025-08-19 Buy 4375.00 Parker Geoffrey M.
2025-08-08 Buy 4060.00 Lockwood-Taylor Patrick

SEC Filings


Form Type Description Pages Date
3 Insider transactions 1 Aug 22, 2025
4/a Other 1 Aug 20, 2025
4 Insider transactions 1 Aug 19, 2025
4 Insider transactions 1 Aug 19, 2025
4 Insider transactions 1 Aug 08, 2025
8-k 8K-related 15 Aug 06, 2025
10-q Quarterly Reports 114 Aug 06, 2025
8-k 8K-related 16 Jul 14, 2025
4 Insider transactions 1 Jul 14, 2025
4 Insider transactions 1 Jul 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy